Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Corrigendum to 'Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study' [European Journal of Cancer 154 (2021) 246-252].
Fazio N, Gervaso L, Halfdanarson TR, La Salvia A, Hofland J, Hernando J, Sonbol MB, Garcia-Carbonero R, Capdevila J, de Herder WW, Koumarianou A, Kaltsas G, Rossi M, Grozinsky-Glasberg S, Oleinikov K, Boselli S, Tamayo D, Bagnardi V, Laffi A, Rubino M, Spada F. Fazio N, et al. Among authors: laffi a. Eur J Cancer. 2022 Jan;160:289-290. doi: 10.1016/j.ejca.2021.10.001. Epub 2021 Oct 21. Eur J Cancer. 2022. PMID: 34690038 Free PMC article. No abstract available.
Case Report: Should Regorafenib be prescribed as a continuous schedule in gastrointestinal stromal tumors? Three case reports on Regorafenib personalized schedule.
Grimaudo MS, Laffi A, Gennaro N, Fazio R, D'Orazio F, Samà L, Siracusano LV, Sicoli F, Renne SL, Santoro A, Bertuzzi AF. Grimaudo MS, et al. Among authors: laffi a. Front Oncol. 2023 May 31;13:1190123. doi: 10.3389/fonc.2023.1190123. eCollection 2023. Front Oncol. 2023. PMID: 37324004 Free PMC article.
Systemic therapies in patients with advanced well-differentiated pancreatic neuroendocrine tumors (PanNETs): When cytoreduction is the aim. A critical review with meta-analysis.
Pozzari M, Maisonneuve P, Spada F, Berruti A, Amoroso V, Cella CA, Laffi A, Pellicori S, Bertani E, Fazio N. Pozzari M, et al. Among authors: laffi a. Cancer Treat Rev. 2018 Dec;71:39-46. doi: 10.1016/j.ctrv.2018.10.008. Epub 2018 Oct 13. Cancer Treat Rev. 2018. PMID: 30352319 Review.
41 results